Deciphera Pharma Scores A Sell-Side Recommendation By: Benzinga via Benzinga February 16, 2018 at 12:59 PM EST Deciphera Pharmaceuticals Inc (NASDAQ: DCPH)’s kinase switch control platform has largely gone unnoticed on the Street. The ... Read More >> Related Stocks: Blueprint Medicines Corp Deciphera Pharmaceuticals Inc Pfizer